hsa-mir-490: Hsa-mir-490 is a microRNA that has been relatively less studied in the context of tumor formation and progression in breast cancer [PMC5013276]. Low expression of hsa-mir-490 has been associated with reduced patient survival in hepatocellular carcinoma [PMC10083302]. In lung adenocarcinoma, hsa-mir-490 has been found to be associated with prognosis, along with other mRNAs, lncRNAs, and miRNAs [PMC7314420]. Limited information is available regarding the regulatory role of hsa-mir-490 in Wilms tumor, but high expression of hsa-mir-490 has been related to high survival rates in patients [PMC6668497]. In breast cancer patients, hsa-mir-490 is one of the miRNAs significantly correlated with overall survival [PMC6692470]. In a study on ovarian cancer drug resistance, hsa-mir-490 was found to play a potential role [PMC5123339]. Additionally, hsa-mir-490 has been identified as one of the miRNAs that may have an important regulatory role in HER2 breast cancer and its associated pathways [PMC5123339]. Overall, while there is relatively less research on hsa-mir-490 compared to other miRNAs, its expression and association with prognosis have been studied in various types of cancer.